British bank Barclays posted a rise in full-year pre-tax profit that came in just ahead of analyst expectations, while also launching a £1 billion share buyback. Pretax profit rose by 24% to £8.108 billion in 2024, just above analyst expectations of £8.081 billion, according to LSEG.
Barclays reported a 24% rise in annual pretax profit on Thursday, slightly above expectations, as its investment bank reported strong performance for 2024 and slower than expected interest rate cuts sustained income in its domestic lending business.
Here is how Northern Trust Corporation (NTRS) and Barclays (BCS) have performed compared to their sector so far this year.
Dan Levy, Barclays senior equity research analyst, joins 'Squawk box' to discuss the impact of tariffs on the auto industry, the likelihood of tariffs being implemented, state of the auto industry, and more.
The market for 'biodiversity net gain' units has been thriving since the regulation came into force a year ago, according to the Environment Bank, though others have criticised the scheme for a lack of ambition. Exactly a year ago, the Department for Environment, Food & Rural Affairs introduced a mandatory minimum of 10% biodiversity net gain for developers, making sure habitats for wildlife "are left in a measurably better state than they were before the development".
Barclays (BCS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does Barclays (BCS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Venu Krishna, Barclays head of U.S. equity linked strategies, joins CNBC's 'Squawk on the Street' to discuss the impact of potential tariffs on markets, what sectors are most at risk, and more.
Carole Madjo, head of European luxury goods research at Barclays, weighs in on the outlook for the luxury sector as firms look for ways to respond to weaker consumer demand.
Barclays PLC will be the first to report of the UK bank results season, next Thursday, 13 February, followed in quick succession by Natwest on Friday, Lloyds the following Monday and then the Asia-focused HSBC and Standard Chartered later that week. Shares in Barclays have been the best performing over the past 52 weeks, up around 109%, with the FTSE 350 Banks index up almost 50% to the highest level since 2008.
Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity drug market.
BCS completes the sale of its German consumer finance business. This is part of its initiative to streamline operations and focus on profitable ones.